Viewing Study NCT06304961


Ignite Creation Date: 2025-12-24 @ 11:48 AM
Ignite Modification Date: 2026-03-28 @ 3:48 AM
Study NCT ID: NCT06304961
Status: COMPLETED
Last Update Posted: 2024-09-19
First Post: 2024-03-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Investigate Relative Bioavailability of Two Different Dosage Forms for Tozorakimab Via Subcutaneous Administration in Healthy Volunteers
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Participants View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Human immunoglobulin G1 monoclonal antibody View
None Chronic Obstructive Pulmonary Disease View
None Asthma View
None Pharmacokinetics View
None Bioavailability View